S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Is this AI's biggest breakthrough to date? (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Tech insider: "Watch your mailbox" (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
Laser breakthrough could send stock soaring 2,467% (Ad)
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Is this AI's biggest breakthrough to date? (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Tech insider: "Watch your mailbox" (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
Laser breakthrough could send stock soaring 2,467% (Ad)
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Is this AI's biggest breakthrough to date? (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Tech insider: "Watch your mailbox" (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
Laser breakthrough could send stock soaring 2,467% (Ad)
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Is this AI's biggest breakthrough to date? (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Tech insider: "Watch your mailbox" (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
Laser breakthrough could send stock soaring 2,467% (Ad)
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
NASDAQ:SGHT

Sight Sciences (SGHT) Stock Price, News & Analysis

$4.43
+0.13 (+3.02%)
(As of 02/23/2024 ET)
Today's Range
$4.24
$4.51
50-Day Range
$3.15
$5.89
52-Week Range
$1.04
$11.27
Volume
155,532 shs
Average Volume
161,252 shs
Market Capitalization
$215.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.60

Sight Sciences MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
3.8% Upside
$4.60 Price Target
Short Interest
Healthy
5.87% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.58mentions of Sight Sciences in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$16.86 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.27) to ($1.18) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.01 out of 5 stars

Medical Sector

796th out of 940 stocks

Surgical & Medical Instruments Industry

86th out of 93 stocks


SGHT stock logo

About Sight Sciences Stock (NASDAQ:SGHT)

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.

SGHT Stock Price History

SGHT Stock News Headlines

Gold explodes past $2,000, here's what's next
After what feels like nearly a decade of disappointing returns, gold is entering a new bull market. You can get started today for just $5.
Sight Sciences (SGHT) to Expand in Europe With New Launch
Free Stock Analysis Report: See The True Value of Any Stock
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Sight Sciences Stock (NASDAQ:SGHT) Insider Trades
See More Headlines
Receive SGHT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sight Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/13/2023
Today
2/25/2024
Next Earnings (Confirmed)
3/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:SGHT
Fax
N/A
Employees
250
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$4.60
High Stock Price Target
$5.50
Low Stock Price Target
$4.00
Potential Upside/Downside
+3.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
6 Analysts

Profitability

Net Income
$-86,240,000.00
Pretax Margin
-74.42%

Debt

Sales & Book Value

Annual Sales
$82.85 million
Book Value
$3.32 per share

Miscellaneous

Free Float
35,539,000
Market Cap
$215.96 million
Optionable
Optionable
Beta
2.85
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Paul Badawi (Age 49)
    Co-Founder, President, CEO & Director
    Comp: $920.3k
  • Dr. David Badawi M.D. (Age 54)
    Founder, CTO & Director
  • Mr. Sam Boong Park (Age 63)
    Chief Operating Officer
    Comp: $531.78k
  • Ms. Alison Perry Bauerlein (Age 43)
    CFO & Treasurer
  • Mr. Jeremy B. Hayden (Age 54)
    Chief Legal Officer
  • Mr. Steve R. Tamayo Jr.
    VP and Chief Ethics & Compliance Officer
  • Dr. Reay H. Brown
    Chief Medical Officer
  • Tom Huang
    Head of Corporate Strategy & Development
  • Mr. Matthew W. Link (Age 49)
    Chief Commercial Officer
  • Mr. Stephen B. Thau J.D.
    Secretary














SGHT Stock Analysis - Frequently Asked Questions

Should I buy or sell Sight Sciences stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sight Sciences in the last twelve months. There are currently 1 sell rating, 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" SGHT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SGHT, but not buy additional shares or sell existing shares.
View SGHT analyst ratings
or view top-rated stocks.

What is Sight Sciences' stock price target for 2024?

6 Wall Street analysts have issued 12-month target prices for Sight Sciences' stock. Their SGHT share price targets range from $4.00 to $5.50. On average, they expect the company's share price to reach $4.60 in the next year. This suggests a possible upside of 3.8% from the stock's current price.
View analysts price targets for SGHT
or view top-rated stocks among Wall Street analysts.

How have SGHT shares performed in 2024?

Sight Sciences' stock was trading at $5.16 at the beginning of the year. Since then, SGHT stock has decreased by 14.1% and is now trading at $4.43.
View the best growth stocks for 2024 here
.

When is Sight Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 7th 2024.
View our SGHT earnings forecast
.

How can I listen to Sight Sciences' earnings call?

Sight Sciences will be holding an earnings conference call on Thursday, March 7th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Sight Sciences' earnings last quarter?

Sight Sciences, Inc. (NASDAQ:SGHT) released its quarterly earnings data on Monday, March, 13th. The company reported ($0.35) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.42) by $0.07. The company earned $20.54 million during the quarter, compared to analysts' expectations of $20.38 million. Sight Sciences had a negative trailing twelve-month return on equity of 43.37% and a negative net margin of 74.55%. During the same period in the prior year, the business earned ($0.34) EPS.

What guidance has Sight Sciences issued on next quarter's earnings?

Sight Sciences issued an update on its fourth quarter 2023 earnings guidance on Monday, January, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $18.6 million-$18.8 million, compared to the consensus revenue estimate of $18.2 million.

When did Sight Sciences IPO?

(SGHT) raised $150 million in an initial public offering on Thursday, July 15th 2021. The company issued 6,980,000 shares at a price of $20.00-$23.00 per share.

Who are Sight Sciences' major shareholders?

Sight Sciences' stock is owned by a number of retail and institutional investors. Top institutional shareholders include UBS Group AG (5.94%), Jackson Square Partners LLC (3.34%), Vanguard Group Inc. (3.02%), Northern Trust Corp (0.41%), Charles Schwab Investment Management Inc. (0.40%) and Point72 Asset Management L.P. (0.40%). Insiders that own company stock include D1 Capital Partners LP, David Badawi, Jeremy B Hayden, Jesse Selnick, Paul Badawi, Sam Boong Park and Staffan Encrantz.
View institutional ownership trends
.

How do I buy shares of Sight Sciences?

Shares of SGHT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SGHT) was last updated on 2/25/2024 by MarketBeat.com Staff